← Back to guidelines
Dermatology7 papers

Basal cell carcinoma - keratotic

Last edited: 4/10/2026

Overview

Keratotic basal cell carcinoma (BCC) is a subtype of basal cell carcinoma, a common type of skin cancer. BCCs arise from the basal cells of the epidermis.

Diagnosis

  • Artificial intelligence (AI) algorithms trained on dermoscopic and macroscopic clinical images show promise for diagnosing BCC.
  • AI models in a systematic review averaged 90% overall accuracy, 87% sensitivity, and 91% specificity for tumor detection 1.
  • Model performance has improved over time 1.
  • Limitations of current AI models include a paucity of external validation and limited representation of certain skin types 1.
  • Management

  • No management strategies for keratotic basal cell carcinoma were discussed in the provided abstracts.
  • Special Populations

  • No information regarding special populations was provided in the abstracts.
  • Key Recommendations

  • Artificial intelligence shows potential for the diagnosis of basal cell carcinoma, with reported average accuracies of 90% 1. (Evidence: Moderate)
  • Further research should prioritize robustness in data reporting, inclusivity in data collection, and interdisciplinary collaboration for the development of effective AI tools for skin cancer diagnosis 1. (Evidence: Expert opinion)
  • References

    1 Jairath N, Pahalyants V, Shah R, Weed J, Carucci JA, Criscito MC. Artificial Intelligence in Dermatology: A Systematic Review of Its Applications in Melanoma and Keratinocyte Carcinoma Diagnosis. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2024. link

    Original source

    1. [1]
      Artificial Intelligence in Dermatology: A Systematic Review of Its Applications in Melanoma and Keratinocyte Carcinoma Diagnosis.Jairath N, Pahalyants V, Shah R, Weed J, Carucci JA, Criscito MC Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG